In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to have a positive start to the week. At the time of writing the benchmark index is up 0.1% to 5,686 points.
Four shares which have started the week with strong gains are listed below. Here’s why they are higher:
The Bubs Australia Ltd (ASX: BUB) share price is up 4% to 54 cents despite there being no news out of the infant formula company. While I saw value in its shares when they drifted down to 45 cents, I feel now they have rallied to 54 cents they ought to be classed as a hold.
The GetSwift Ltd (ASX: GSW) share price appears to have shaken off the profit takers and has climbed 8% to $2.15. The logistic platform provider’s shares have more than doubled in value in less than a month thanks to a game-changing contract with US-giant NA Williams. Despite the strong gain, I still believe GetSwift is a great buy and hold investment option.
The Mayne Pharma Group Ltd (ASX: MYX) share price has rebounded from last week’s drop with a 3% rise to 67.5 cents. The pharmaceutical company’s shares fell 11% last week as concerns over competitive pressures in the U.S. generic drugs market weighed heavily on its shares.
The Mesoblast limited (ASX: MSB) share price has climbed almost 4% to $1.39 after the innovative cell-based medicines developer advised that its will present corporate updates at two healthcare conferences in New York this week. The focus will be on the Phase 3 clinical trials of its lead product candidates in acute graft versus host disease, chronic low back pain due to disc degeneration, and chronic heart failure.
Missed these gains? Don't worry because these hot shares may be next in line for big gains if you ask me.
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor James Mickleboro owns shares of GetSwift Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.